BILL · 2025–26 SESSION
HB 1741: PANDAS, pediatric treatment
Expanding access to treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome.
Did not pass Did not pass · died in committee
- IntroducedJan 30, 2025
- Out of committeestopped here
- Passed House
- Passed Senate
- Governor
- Law
- Prime sponsor
- My-Linh Thai (D-41)
- Introduced
- January 30, 2025 in the House
- Last action
- January 12, 2026
- Budget
- Has a fiscal note
AN ACT Relating to expanding access to treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome;
Sponsors
Prime sponsor: My-Linh Thai (D-41)
9 co-sponsors (8 Democrats, 1 Republican)
Votes
No recorded floor votes. This measure never reached a floor vote.
History
- By resolution, reintroduced and retained in present status.
- First reading, referred to Health Care & Wellness.
HB 1741 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
- HB 1741 (2023–24) Prototypical school formulas
- HB 1741 (2021–22) Health provider contracting
- HB 1741 (2019–20) Rabies antibody titers
- HB 1741 (2017–18) Educator prep. data/PESB
- HB 1741 (2015–16) Disabled/rec lands pass exem
- HB 1741 (2013–14) Retirees/insurance programs
- HB 1741 (2011–12) Temp assist/needy families
- HB 1741 (2009–10) School employees dismissal